164 related articles for article (PubMed ID: 37210978)
1. Female Recruitment Into Cardiovascular Disease Trials.
Wu Y; Prasanna A; Miller HN; Ogungbe O; Peeler A; Juraschek SP; Turkson-Ocran RA; Plante TB
Am J Cardiol; 2023 Jul; 198():88-91. PubMed ID: 37210978
[No Abstract] [Full Text] [Related]
2. Success in recruitment to randomized clinic trials: keep it simple and close to home … or is there more to it?
Frye RL
J Am Coll Cardiol; 2013 Feb; 61(7):770-1. PubMed ID: 23410548
[No Abstract] [Full Text] [Related]
3. The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.
Tsang W; Alter DA; Wijeysundera HC; Zhang T; Ko DT
J Gen Intern Med; 2012 Jan; 27(1):93-8. PubMed ID: 21713543
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of Black Adults into Cardiovascular Disease Trials.
Prasanna A; Miller HN; Wu Y; Peeler A; Ogungbe O; Plante TB; Juraschek SP
J Am Heart Assoc; 2021 Sep; 10(17):e021108. PubMed ID: 34431310
[TBL] [Abstract][Full Text] [Related]
5. Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials.
Ghare MI; Chandrasekhar J; Mehran R; Ng V; Grines C; Lansky A
JACC Cardiovasc Interv; 2019 Feb; 12(3):301-308. PubMed ID: 30732736
[TBL] [Abstract][Full Text] [Related]
6. Underrepresentation of peripheral artery disease in modern cardiovascular trials: systematic review and meta-analysis.
Vyas MV; Mrkobrada M; Donner A; Hackam DG
Int J Cardiol; 2013 Oct; 168(5):4875-6. PubMed ID: 23896535
[No Abstract] [Full Text] [Related]
7. Boosting Women's Participation in Cardiovascular Trials: More Work Needed to Match Real-World Epidemiology for Heart Failure, Coronary Artery Disease, and Acute Coronary Syndrome.
Kuehn BM
Circulation; 2018 Sep; 138(13):1366-1367. PubMed ID: 30354415
[No Abstract] [Full Text] [Related]
8. A systematic overview to quantify the gender imbalance in cardiovascular rehabilitation trials.
Cugusi L; Mercuro G
Eur J Prev Cardiol; 2019 May; 26(7):776-781. PubMed ID: 30400760
[No Abstract] [Full Text] [Related]
9. Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era.
Maini R; Wong DB; Addison D; Chiang E; Weisbord SD; Jneid H
J Am Soc Nephrol; 2018 Dec; 29(12):2782-2786. PubMed ID: 30389726
[No Abstract] [Full Text] [Related]
10. Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
Mathew RO; Bangalore S; Sidhu MS; Fleg JL; Maddux FW
Kidney Int; 2018 Apr; 93(4):787-788. PubMed ID: 29571453
[No Abstract] [Full Text] [Related]
11. Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease: Time for Action.
Zannad F; Rossignol P
Circulation; 2017 May; 135(19):1769-1771. PubMed ID: 28483826
[No Abstract] [Full Text] [Related]
12. Women in clinical trials--a portfolio for success.
Buring JE
N Engl J Med; 2000 Aug; 343(7):505-6. PubMed ID: 10944570
[No Abstract] [Full Text] [Related]
13. Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review.
Konstantinidis I; Nadkarni GN; Yacoub R; Saha A; Simoes P; Parikh CR; Coca SG
JAMA Intern Med; 2016 Jan; 176(1):121-4. PubMed ID: 26619332
[No Abstract] [Full Text] [Related]
14. Challenges in recruitment to a randomized controlled study of cardiovascular disease reduction in sleep apnea: an analysis of alternative strategies.
Gleason K; Shin D; Rueschman M; Weinstock T; Wang R; Ware JH; Mittleman MA; Redline S
Sleep; 2014 Dec; 37(12):2035-8. PubMed ID: 25325506
[TBL] [Abstract][Full Text] [Related]
15. Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.
Vitale C; Rosano G; Fini M
Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):433-438. PubMed ID: 27655475
[TBL] [Abstract][Full Text] [Related]
16. The several faces of clinical trials: from new therapies to failed preventive strategies.
Fuster V
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):173. PubMed ID: 16568110
[No Abstract] [Full Text] [Related]
17. Status of women in cardiovascular clinical trials.
Kim ES; Menon V
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):279-83. PubMed ID: 19221204
[No Abstract] [Full Text] [Related]
18. Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.
Bernardez-Pereira S; Lopes RD; Carrion MJ; Santucci EV; Soares RM; de Oliveira Abreu M; Laranjeira LN; Ikeoka DT; Zazula AD; Moreira FR; Cavalcanti AB; Mesquita ET; Peterson ED; Califf RM; Berwanger O;
Am Heart J; 2014 Aug; 168(2):213-9.e1. PubMed ID: 25066561
[TBL] [Abstract][Full Text] [Related]
19. Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.
Jin X; Chandramouli C; Allocco B; Gong E; Lam CSP; Yan LL
Circulation; 2020 Feb; 141(7):540-548. PubMed ID: 32065763
[TBL] [Abstract][Full Text] [Related]
20. Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy.
Nanna MG; Chen ST; Nelson AJ; Navar AM; Peterson ED
JAMA Intern Med; 2020 Nov; 180(11):1531-1533. PubMed ID: 32897289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
